Why the study?
Evidence on the prognostic impact of right ventricle to pulmonary artery coupling among M-TEER patients remains inconsistent due to divergent definitions.
Does RV-PA uncoupling (TAPSE/D-PASP < 0.37 mm/mmHg) predict worse long-term survival in patients undergoing M-TEER for severe mitral regurgitation?
Observational (n=158)
Does RV-PA uncoupling (TAPSE/D-PASP < 0.37 mm/mmHg) predict worse long-term survival in patients undergoing M-TEER for severe mitral regurgitation?
Answers are grounded in this paper and cite their sources.
A TAPSE/D-PASP ratio < 0.37 mm/mmHg is a feasible echocardiographic marker that identifies patients with advanced heart failure and worse survival outcomes following M-TEER.
Background Transcatheter edge-to-edge mitral valve repair (M-TEER) represents an effective treatment modality for high-grade mitral valve regurgitation. The right ventricle (RV) to pulmonary artery (PA) coupling ratio has been indicated as a marker of right ventricular dysfunction (RVD), but evidence among M-TEER patients remains inconsistent to date due to divergent definitions. We therefore aimed to shed light on the impact of RV-PA uncoupling on survival following M-TEER. Methods Data from all patients who underwent M-TEER and provided sufficient echocardiographic data were investigated. RV-PA uncoupling was defined as the ratio of tricuspid annular pulse systolic excursion (TAPSE) and to the Doppler echocardiographic-derived pulmonary artery systolic pressure (D-PASP) < 0.37 mm/mmHg. The difference in long-term survival between patients with and without RV-PA uncoupling were analyzed via the Kaplan-Meier method, and independent predictors of mortality were identified via uni- and multivariable Cox regression analyses. Results A total of 158 patients were eligible for analysis, and RV-PA uncoupling was present in 32.3% of the patients (51/158). Patients with RV-PA uncoupling presented significantly advanced congestive heart failure stages. While M-TEER was performed equally safely in patients with RV-PA uncoupling (odds ratio for procedural success: 0.95, 95% confidence interval [CI] 0.29–2.77, p = 0.9), their long-term survival three years after M-TEER was significantly worse (50.9% (26/51) vs. 61.7% (66/107), p = 0.01). In this regard, a TAPSE/D-PASP ratio < 0.37 mm/mmHg proved to be a more consistent discriminator of long-term survival than a TAPSE < 18 mm alone. Conclusion RV-PA uncoupling, defined as a TAPSE/D-PASP ratio of < 0.37 mm/mmHg, is a feasible and reproducible parameter, which also serves as a marker for advanced congestive heart failure and worse survival outcomes.
No takes yet. Share an insight, caveat, or question.
Ausbuettel et al. (2026) conducted an observational in Severe mitral regurgitation (n=158). RV-PA uncoupling (TAPSE/D-PASP ratio < 0.37 mm/mmHg) vs. No RV-PA uncoupling was evaluated on Long-term survival at three years (p=0.01).
Synapse has enriched 10 related papers. Consider them for comparative context: